Results 41 to 50 of about 22,846,314 (192)
Journal of Tehran University Heart Center, 2018 Background: Despite recent advances in interventional equipment and techniques, the angiographic no-reflow phenomenon occurs in a considerable number of patients undergoing primary percutaneous coronary intervention (PCI).
Mohammad Alidoosti +6 more
doaj +1 more source
The No-Reflow Phenomenon: Clinical and Angiographic Correlates [PDF]
, 2016 No-reflow occurring during PCI has been associated with poor outcomes. The objectives of this study were to evaluate the incidence of no-reflow as independent predictor of adverse events and to assess whether baseline pre-procedural treatment options may
Cenko, Edina <1981>
core +1 more source
Inflammation-Based C-Reactive Protein-to-Albumin Ratio for No-Reflow Prediction in STEMI
BiomedicinesBackground: The C-reactive protein/albumin ratio (CAR) has increasingly attracted attention as a reliable predictive marker in patients with acute myocardial infarction (AMI).
Xhevdet Krasniqi +5 more
doaj +1 more source
Anatolian Journal of Cardiology, 2022 Background: No-reflow phenomenon after primary percutaneous coronary intervention is a common condition affecting the outcomes; therefore, studying its predictive factors is helpful in identifying patients at high risk.
Mohamed Khalfallah +2 more
doaj +1 more source
The no-reflow phenomenon: State of the art
Archives of Cardiovascular Diseases, 2015 Primary percutaneous coronary intervention (PCI) is the best available reperfusion strategy for acute ST-segment elevation myocardial infarction (STEMI), with nearly 95% of occluded coronary vessels being reopened in this setting. Despite re-establishing epicardial coronary vessel patency, primary PCI may fail to restore optimal myocardial reperfusion ...
Bouleti, C., Mewton, Nathan, Germain, S.
openaire +3 more sources
Interleukin-34 as a Robust Predictor of No-Reflow Phenomenon in ST-Elevation Myocardial Infarction: Insights into Inflammatory Mechanisms and Clinical Implications [PDF]
Objective: ST-elevation myocardial infarction (STEMI) poses a significant challenge despite advances in reperfusion strategies. The “no-reflow” phenomenon, characterized by inadequate microvascular blood flow restoration following successful ...
Hasan Ata Bolayır +2 more
core +1 more source
Myocardial no-reflow in humans [PDF]
, 2009 In a variable proportion of patients presenting with ST-segment elevation myocardial infarction, ranging from 5% to 50%, primary percutaneous coronary intervention achieves epicardial coronary artery reperfusion but not myocardial reperfusion, a ...
Crea, Filippo +7 more
core +2 more sources
The "no-reflow" phenomenon in the coronary arteries [PDF]
Arquivos Brasileiros de Cardiologia, 1999 In the last twenty years, the treatment of coronary heart disease with cardiac catheterization has greatly advanced. This therapeutic approach has had unexpected side effects, however, for which solutions must be found, particularly in the are of interventional cardiology. The “noreflow” phenomenon, a side effect, is an uncommon and critical occurrence
Antônio Esteves Fº +2 more
doaj +4 more sources
Scalable Fabrication of Chemically Stabilized Gelatin Hydrogel Fibers by Thermal Drawing
Advanced Materials Interfaces, EarlyView.Scalable processing of hydrogel fibers remains a major challenge. By coupling thermal drawing with Maillard chemistry, a transient viscous‐flow window is created that enables continuous fabrication of microstructured gelatin fibers tens of meters long, while continued in situ crosslinking during drawing stabilizes the fibers for physiological ...
Chaoqun Dong +5 more
wiley +1 more source
Advanced Robotics Research, EarlyView.Micro‐ and nanorobots for targeted thrombolysis. This perspective elaborates on the clinical indication of blood clot disorders and current limitations for treatment. As a novel, alternative solution, micro‐ and nanorobots can be used to treat and break down thrombi.
Joshua M. Mesfin +3 more
wiley +1 more source